新型抗体技术

• Merus N.V. Announces Proposed Public Offering of Common Shares 2021-01-20
• Proteintech Acquires ChromoTek, Expanding its Next Generation Antibody Tools 2020-10-20
• 港股消息丨临床后期生物制药公司云顶新耀-B高开28.27%，涨超30% 2020-10-09
• ADC Therapeutics Announces Proposed Public Offering 2020-09-22
• Agenus Receives $35M In Immuno-Oncology Transaction with Betta Pharmaceuticals 2020-07-29
• Tubulis Raises €10.7 M Series A to Advance Development of a New Generation of Antibody-Drug Conjugates 2020-07-21
• ADC抗体| VelosBio完成1.37亿美元B轮融资 2020-07-08
• 快讯| 和铂医药完成7500万美元的B+轮融资，以加速创新管道的开发 2020-03-12
• 战略布局多特异性抗体 三生国健1500万瑞士法郎领投Numab Therapeutics 2020-03-09
• 生物技术公司MiroBio完成3400万美元A轮融资，开发自身免疫性疾病治疗药物 2019-10-10

登录医药魔方官网 查看更多资讯